MedTrace Logo

Comparison of Performance of a Conventional Blood Gas Analyser With the Proxima System

NCT01921023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2014-11-18

No results posted yet for this study

Summary

This clinical investigation is being undertaken to examine the performance of the CE marked Proxima System - a patient attached blood gas analyser.

The study forms an element of the Post Market surveillance plan for the Proxima system and will also generate method comparison data to allow Sphere Medical to submit the Proxima for FDA regulatory clearance.

Conditions

  • Analysis, Event History

Sponsors & Collaborators

  • Sphere Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Thomas Clutton-Brock, MB ChB FRCA FRCP FFICM · Queen Elizabeth Hopsital, Birmingham, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United Kingdom

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01921023 on ClinicalTrials.gov